ABOS - Acumen Pharmaceuticals, Inc.
2.26
-0.290 -12.832%
Share volume: 919,327
Last Updated: 03-27-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$2.55
-0.29
-0.11%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-12-2024 | 03-27-2025 | 05-13-2025 | 11-12-2025 | 03-26-2026 | |
| Cash flow financing | 7.107 M | -128.000 K | -42.000 K | -9.000 K | -36.000 K | 0.000 | 2.000 K | |
| Other financing cash flows | -831.000 K | -128.000 K | -42.000 K | -9.000 K | -36.000 K | 0.000 | 2.000 K | |
| Cash flow | -19.955 M | 21.026 M | -34.770 M | 2.439 M | -5.468 M | 0.000 | 7.156 M | |
| Net income | -14.873 M | -20.537 M | -29.765 M | -37.154 M | -28.796 M | -26.451 M | -25.138 M | |
| Depreciation | 16.000 K | 17.000 K | 16.000 K | 14.000 K | 15.000 K | 15.000 K | 12.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -9.203 M | 37.699 M | -10.132 M | 29.663 M | 28.689 M | 40.511 M | 26.250 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 11.000 K | 5.000 K | 0.000 | 0.000 | 79.000 K | 0.000 | 0.000 | |
| Cash Change | -19.955 M | 21.026 M | -34.770 M | 2.439 M | -5.468 M | 10.022 M | 7.156 M |